Ottawa Belly Casts

transplantation

Including several deaths.

Dr. Bruce Lavin, vice president of internal medication for Sanofi-Aventis, said Ketek remains a choice needed by doctors when they treat people who are contaminated with bacteria which have developed resistance to other antibiotics. The label modification comes as the Senate Finance Committee investigates allegations of fraud linked to trials of Ketek, and also how the FDA has handled safety issues linked to the drug. ‘There are queries about whether this drug should stay on the market, and there’s great legitimacy to those queries. Continue reading